Perceptive Advisors Invests $49.9M in Solid Biosciences Private Placement, Boosting Stake to 12.9%

summarizeSummary

Perceptive Advisors disclosed a $49.9 million investment in Solid Biosciences' recent private placement, acquiring pre-funded warrants and increasing its beneficial ownership to 12.9%.

check_boxKey Events

• Major Investment in Private Placement

  Perceptive Advisors, through its Master Fund, acquired 8,912,655 pre-funded warrants for $49.9 million in Solid Biosciences' private placement, which closed on March 9, 2026.

• Increased Beneficial Ownership

  This investment increases Perceptive Advisors' beneficial ownership in Solid Biosciences to 12.9% of the outstanding common stock.

• Warrant Exercise Limitation

  The pre-funded warrants include a beneficial ownership limitation, preventing exercise if it would result in ownership exceeding 9.99%.

• Follows Previously Announced Capital Raise

  This disclosure details a significant participant in the $240 million private placement announced by Solid Biosciences on March 6, 2026, and follows other investor disclosures related to the same event.

auto_awesomeAnalysis

This Schedule 13D/A filing reveals Perceptive Advisors' substantial participation in Solid Biosciences' recently announced $240 million private placement. The $49.9 million investment, through the acquisition of pre-funded warrants, significantly increases Perceptive's beneficial ownership to 12.9%. While the warrants have a 9.99% exercise limitation, this large investment by a prominent life sciences investor signals strong institutional confidence in Solid Biosciences, especially following the positive clinical data reported on March 11, 2026. This capital infusion, detailed by a major investor, strengthens the company's financial position and extends its cash runway.